Unfortunately, your concerns and observations are

Unfortunately, your concerns and observations are on point, there will be a need of more authorized shares, which seems obvious based on our situation. The thing is, it does not matter how amazing the molecule is, and it’s potential to cure and help with a lot of indications, we need $. We are not a revenue generating company. Se we live off loans and shareholders $. After 5 years here, there is NO WAY, it is obvious to say we will never make it on our own. NO WAY. We should sell. SELL or partner to get trials going and potential approval on some indication to be able to survive and thrive . We have a new President with 12 years experience! I hope he is a sharp enough to prove it is long enough to cut a deal, and make this company successful.